Tania Stallons

Tania Stallons has been Head of CMC at Orano Med since 2022. With over 10 years of industry experience, she has built strong expertise in early phase radiopharmaceutical drug development. She joined Orano Med in 2014 and has held various scientific positions, leading a team in drug optimization, characterization and CMC regulatory preparation. Before joining Orano Med, Tania spent 2 years as a postdoctoral research associate at Scripps Florida studying the role of DNA damage and repair in aging.

Tania graduated from Florida Institute of Technology with a B.S. in Molecular Biology and a Ph.D. in Biological Sciences.